Moolec Science (MLEC) Land & Improvements (2024 - 2025)
Moolec Science (MLEC) reported Land & Improvements of $100896.0 for Q2 2025, down 99.32% on a YoY basis from $14.9 million in Q2 2024, and down 99.32% sequentially from $14.9 million in Q2 2024.
Moolec Science (MLEC) Land & Improvements (2024 - 2025) Analysis & Trends
Moolec Science (MLEC) has 2 years of Land & Improvements data on file, last reported at $100896.0 in Q2 2025.
- For the quarter ending Q2 2025, Land & Improvements fell 99.32% year-over-year to $100896.0; the trailing twelve-month figure through Jun 2025 stood at $100896.0 (down 99.32% YoY), and the FY2025 full-year result was $100896.0, down 99.32% from the prior year.
- Land & Improvements slipped to $100896.0 in Q2 2025, from $14.9 million in the prior quarter.
- In the past five years, Land & Improvements ranged from a high of $14.9 million in Q2 2024 to a low of $100896.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Land & Improvements (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Moolec Science | 5.21 Bn | 5.21 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 100,896.00 |
| Jun 30, 2024 | 14.92 Mn |